TorreyPines Therapeutics
Pharmaceutical ManufacturingUnited States11-50 Employees
TorreyPines Therapeutics operates in the pharmaceutical manufacturing sector in the United States, with a focus reflected in its historical associations with Prana Biotechnology and related leadership appointments. The available information indicates a small to mid-sized company, and it has engaged in activities and leadership changes that align with strategic development in biotech and neurological research. The firm’s public profile references its LinkedIn presence and outlines a connection to Pranabio, including executive hires and board-level appointments over the years, suggesting a role in advancing therapeutic programs within neuroscience. A recent development noted in the provided material is the leadership and management changes associated with Pranabio, including appointments to chief executive and chief medical officer positions, and a notable investment from Life Biosciences in Prana Biotechnology, which signals ongoing activity in its ecosystem. The company is headquartered in the United States and operates within a competitive pharmaceutical landscape that includes large industry players, while maintaining a focus on specialized therapeutic research and development.